Avicanna Inc. (AVCN.TO)

CAD 0.24

(0.0%)

Total Debt Summary of Avicanna Inc.

  • Avicanna Inc.'s latest annual total debt in 2023 was 1.8 Million CAD , down -43.81% from previous year.
  • Avicanna Inc.'s latest quarterly total debt in 2024 Q2 was 1.56 Million CAD , down -11.38% from previous quarter.
  • Avicanna Inc. reported annual total debt of 3.2 Million CAD in 2022, up 93.1% from previous year.
  • Avicanna Inc. reported annual total debt of 1.66 Million CAD in 2021, down -14.23% from previous year.
  • Avicanna Inc. reported quarterly total debt of 1.76 Million CAD for 2024 Q1, down -1.97% from previous quarter.
  • Avicanna Inc. reported quarterly total debt of 1.8 Million CAD for 2023 Q4, down -15.49% from previous quarter.

Annual Total Debt Chart of Avicanna Inc. (2023 - 2016)

Historical Annual Total Debt of Avicanna Inc. (2023 - 2016)

Year Total Debt Total Debt Growth
2023 1.8 Million CAD -43.81%
2022 3.2 Million CAD 93.1%
2021 1.66 Million CAD -14.23%
2020 1.93 Million CAD 52.48%
2019 1.27 Million CAD 8701.09%
2018 14.44 Thousand CAD 0.0%
2017 - CAD -100.0%
2016 110 Thousand CAD 0.0%

Peer Total Debt Comparison of Avicanna Inc.

Name Total Debt Total Debt Difference
Aurora Cannabis Inc. 104.79 Million CAD 98.279%
Avant Brands Inc. 18.7 Million CAD 90.357%
Cardiol Therapeutics Inc. 158.53 Thousand CAD -1037.56%
Crescita Therapeutics Inc. 1.25 Million CAD -43.812%
Knight Therapeutics Inc. 69.09 Million CAD 97.39%
MediPharm Labs Corp. 2.29 Million CAD 21.421%
OrganiGram Holdings Inc. 155 Thousand CAD -1063.482%
Canopy Growth Corporation 683.17 Million CAD 99.736%
Willow Biosciences Inc. 2.15 Million CAD 16.354%
Auxly Cannabis Group Inc. 159.04 Million CAD 98.866%